Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 1
2006 1
2009 3
2010 2
2013 1
2014 2
2016 4
2017 1
2018 6
2019 5
2020 3
2021 4
2022 5
2023 4
2024 3
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
A narrative review for radiation oncologists to implement preoperative partial breast irradiation.
Zerella MA, Zaffaroni M, Ronci G, Dicuonzo S, Rojas DP, Morra A, Gerardi MA, Fodor C, Rondi E, Vigorito S, Penco S, Sargenti M, Baratella P, Vicini E, Morigi C, Kahler-Ribeiro-Fontana S, Galimberti VE, Gandini S, De Camilli E, Renne G, Cattani F, Veronesi P, Orecchia R, Jereczek-Fossa BA, Leonardi MC. Zerella MA, et al. Among authors: vigorito s. Radiol Med. 2023 Dec;128(12):1553-1570. doi: 10.1007/s11547-023-01706-6. Epub 2023 Aug 31. Radiol Med. 2023. PMID: 37650981 Review.
Neobladder and ablative pelvic radiotherapy: still a taboo?
Bergamaschi L, Gerardi MA, Zaffaroni M, Augugliaro M, Vigorito S, Rondi E, Della Vigna P, Varano G, Fumagalli Romario U, Biffi R, Picardi EEE, Ferrari A, Jereczek-Fossa BA. Bergamaschi L, et al. Among authors: vigorito s. Tumori. 2021 Dec;107(6):NP108-NP113. doi: 10.1177/03008916211031295. Epub 2021 Jul 8. Tumori. 2021. PMID: 34235994
Stereotactic radiotherapy for managing ovarian cancer oligoprogression under poly (ADP-ribose) polymerase inhibitors (PARPi).
Durante S, Cuccia F, Rigo M, Caminiti G, Mastroleo F, Lazzari R, Corrao G, Caruso G, Vigorito S, Cattani F, Ferrera G, Chiantera V, Alongi F, Colombo N, Jereczek-Fossa BA. Durante S, et al. Among authors: vigorito s. Int J Gynecol Cancer. 2024 Aug 5;34(8):1232-1239. doi: 10.1136/ijgc-2024-005361. Int J Gynecol Cancer. 2024. PMID: 38821546
Intensity-Modulated Radiotherapy (IMRT) following Conservative Surgery of the Supraglottic Region: Impact on Functional Outcomes.
Alterio D, Marani S, Zurlo V, Zorzi SF, Ferrari A, Volpe S, Bandi F, Vigorito S, Vincini MG, Gandini S, Gaeta A, Fodor CI, Casbarra A, Zaffaroni M, Starzyńska A, Belgioia L, Ansarin M, Aristei C, Jereczek-Fossa BA. Alterio D, et al. Among authors: vigorito s. Cancers (Basel). 2022 May 24;14(11):2600. doi: 10.3390/cancers14112600. Cancers (Basel). 2022. PMID: 35681579 Free PMC article.
Brain metastases from NSCLC treated with stereotactic radiotherapy: prediction mismatch between two different radiomic platforms.
Carloni G, Garibaldi C, Marvaso G, Volpe S, Zaffaroni M, Pepa M, Isaksson LJ, Colombo F, Durante S, Lo Presti G, Raimondi S, Spaggiari L, de Marinis F, Piperno G, Vigorito S, Gandini S, Cremonesi M, Positano V, Jereczek-Fossa BA. Carloni G, et al. Among authors: vigorito s. Radiother Oncol. 2023 Jan;178:109424. doi: 10.1016/j.radonc.2022.11.013. Epub 2022 Nov 24. Radiother Oncol. 2023. PMID: 36435336
The dosimetric impact of axillary nodes contouring variability in breast cancer radiotherapy: An AIRO multi-institutional study.
Leonardi MC, Pepa M, Luraschi R, Vigorito S, Dicuonzo S, Isaksson LJ, La Porta MR, Marino L, Ippolito E, Huscher A, Argenone A, De Rose F, Cucciarelli F, De Santis MC, Rossi F, Prisco A, Guarnaccia R, Tabarelli de Fatis P, Palumbo I, Colangione SP, Mormile M, Ravo V, Fozza A, Aristei C, Orecchia R, Cattani F, Jereczek-Fossa BA; Collaborative Italian Association of Radiotherapy and Clinical Oncology (AIRO) Breast Study Group. Leonardi MC, et al. Among authors: vigorito s. Radiother Oncol. 2022 Mar;168:113-120. doi: 10.1016/j.radonc.2022.01.004. Epub 2022 Jan 13. Radiother Oncol. 2022. PMID: 35033602
Impact of inter-observer variability on first axillary level dosimetry in breast cancer radiotherapy: An AIRO multi-institutional study.
Leonardi MC, Pepa M, Zaffaroni M, Vincini MG, Luraschi R, Vigorito S, Morra A, Dicuonzo S, Mazzola GC, Gerardi MA, Zerella MA, Cante D, Petrucci E, Borzì G, Marrocco M, Chieregato M, Iadanza L, Lobefalo F, Valenti M, Cavallo A, Russo S, Guernieri M, Malatesta T, Meaglia I, Liotta M, Palumbo I, Marcantonini M, Mezzenga E, Falivene S, Arrichiello C, Barbero MP, Ivaldi GB, Catalano G, Vidali C, Giannitto C, Ciabattoni A, Meattini I, Aristei C, Orecchia R, Cattani F, Jereczek-Fossa BA. Leonardi MC, et al. Among authors: vigorito s. Tumori. 2023 Dec;109(6):570-575. doi: 10.1177/03008916231196801. Epub 2023 Sep 9. Tumori. 2023. PMID: 37688419 Free PMC article.
Single fraction ablative preoperative radiation treatment for early-stage breast cancer: the CRYSTAL study - a phase I/II clinical trial protocol.
Zerella MA, Zaffaroni M, Ronci G, Dicuonzo S, Rojas DP, Morra A, Fodor C, Rondi E, Vigorito S, Botta F, Cremonesi M, Garibaldi C, Penco S, Galimberti VE, Intra M, Gandini S, Barberis M, Renne G, Cattani F, Veronesi P, Orecchia R, Jereczek-Fossa BA, Leonardi MC. Zerella MA, et al. Among authors: vigorito s. BMC Cancer. 2022 Apr 2;22(1):358. doi: 10.1186/s12885-022-09305-w. BMC Cancer. 2022. PMID: 35366825 Free PMC article.
CyberKnife beam output factor measurements: A multi-site and multi-detector study.
Masi L, Russo S, Francescon P, Doro R, Frassanito MC, Fumagalli ML, Reggiori G, Marinelli M, Redaelli I, Pimpinella M, Verona Rinati G, Siragusa C, Vigorito S, Mancosu P. Masi L, et al. Among authors: vigorito s. Phys Med. 2016 Dec;32(12):1637-1643. doi: 10.1016/j.ejmp.2016.08.001. Epub 2016 Aug 4. Phys Med. 2016. PMID: 27499371
38 results